Source link : https://www.newshealth.biz/health-news/dupilumab-proves-effective-in-chronic-spontaneous-urticaria/
BOSTON — Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) whose symptoms were uncontrolled with H1-antihistamine therapy. The phase III LIBERTY-CUPID study C showed that among children and adults randomized to receive either dupilumab or placebo added to standard-of-care (SoC) H1 antihistamines, those receiving dupilumab experienced an 8.64-point […]
Author : News Health
Publish date : 2024-10-27 21:10:24
Copyright for syndicated content belongs to the linked Source.
